Pascal Deschatelets
Fondateur chez APELLIS PHARMACEUTICALS, INC.
Fortune : 45 M $ au 31/05/2024
Profil
Pascal Deschatelets est un entrepreneur qui a fondé Apellis Pharmaceuticals, Inc, Potentia Pharmaceuticals, Inc, Revon Systems, Inc et Syntetica Fine Chemicals. Il occupe actuellement le poste de directeur scientifique d'Apellis Pharmaceuticals, Inc. Il est également membre du conseil d'administration de Revon Systems, Inc. Pascal Deschatelets a précédemment occupé le poste de directeur de l'exploitation chez Potentia Pharmaceuticals, Inc. Il est titulaire d'un doctorat de l'Université de Montréal.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 20/05/2024 | 1 140 483 ( 0,94% ) | 45 M $ | 31/05/2024 |
Postes actifs de Pascal Deschatelets
| Sociétés | Poste | Début |
|---|---|---|
| APELLIS PHARMACEUTICALS, INC. | Fondateur | 25/09/2009 |
Revon Systems, Inc.
 Revon Systems, Inc. Packaged SoftwareTechnology Services Revon Systems, Inc. operates a platform that connects physicians and patients for medicine. Its products include Revon Patient App, Revon Physician App, Alexa Skill and Research Coordinators Portal. The firm's platform’s digital interface supports data collection for the investigation of the performance of pharmaceutical and other interventions in various patient populations. It enables digital registry services, real world evidence collection and patient reported outcomes tracking for pharmaceutical and medical device companies conducting clinical trials. The company was founded by Cedric Francois and Pascal Deschatelets and is headquartered in Crestwood, KY. | Fondateur | - |
Anciens postes connus de Pascal Deschatelets
| Sociétés | Poste | Fin |
|---|---|---|
Potentia Pharmaceuticals, Inc.
 Potentia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Potentia Pharmaceuticals, Inc. operates as a biotechnology company. It focuses on the development of novel therapeutics and drug delivery technologies to address chronic inflammatory diseases. The company was founded by Cedric Francois, David Darst, Alec Machiels and Pascal Deschatelets in 2001 and is headquartered in Crestwood, KY. | Fondateur | 01/09/2016 |
| Syntetica Fine Chemicals | Fondateur | - |
Formation de Pascal Deschatelets
| University of Montréal | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| APELLIS PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Potentia Pharmaceuticals, Inc.
Potentia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Potentia Pharmaceuticals, Inc. operates as a biotechnology company. It focuses on the development of novel therapeutics and drug delivery technologies to address chronic inflammatory diseases. The company was founded by Cedric Francois, David Darst, Alec Machiels and Pascal Deschatelets in 2001 and is headquartered in Crestwood, KY. | Health Technology |
Revon Systems, Inc.
Revon Systems, Inc. Packaged SoftwareTechnology Services Revon Systems, Inc. operates a platform that connects physicians and patients for medicine. Its products include Revon Patient App, Revon Physician App, Alexa Skill and Research Coordinators Portal. The firm's platform’s digital interface supports data collection for the investigation of the performance of pharmaceutical and other interventions in various patient populations. It enables digital registry services, real world evidence collection and patient reported outcomes tracking for pharmaceutical and medical device companies conducting clinical trials. The company was founded by Cedric Francois and Pascal Deschatelets and is headquartered in Crestwood, KY. | Technology Services |
| Syntetica Fine Chemicals |
